2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3352
  



  

  
Submitter : 
  

  
Mrs. Sage Oliva
  

  
Date & Time: 
  

  
12/15/2006 08:12:19
  



  

  
Organization : 
  

  
Mrs. Sage Oliva
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Vaccine production should not involve the use of aborted fetal cells. It is inherently unsafe to first manufacture and then distribute and then inject foreign genetic material into the bodies of human beings.